$OABI 0.53 Developing
- Date
- Aug 17, 2026
- Mentions
- 3
- Unique authors
- 2
- Sector
- biotech
- Stance
- neutral
- On card
- no
Sentiment history
No sentiment history available for $OABI yet.
Sentiment
Notable posts
-
neutral 55 eng
$OABI SIGNS LILLY DEAL WORTH UP TO $370M OmniAb entered a global collaboration and licensing agreement with Eli Lilly for a new ion channel drug discovery program. OmniAb will receive an upfront payment and is eligible for up to $370M in research, development and commercial milestones, plus tiered royalties on global net sales. The target and therapeutic modality were not disclosed.
view on X → -
neutral 32 eng
OmniAb $OABI raised its 2026 cash guidance following recent licensing activity. The company now expects to end the year with $49M-$53M in cash and equivalents, up from its prior $37M-$41M outlook. https://t.co/OTZOMHu1KT
view on X → -
neutral 15 eng
Tenet Pre-Market Movers August.17.26 $OABI $ARGX $DSX $MESO $HTHT $HIVE $KEEL $HCM $SNDK $BE $SKHY $ETSY $ONTO $MU $EYPT $GLOB $ENVX $GNK $ALH $BALY $GEMI $RPD $MOVE @ripster47 | @tenet_research | @TenetCharts https://t.co/ONvDLNfD8H
view on X →
Only one day of history so far — the signal arc fills in as the daily job runs.